PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
PU.1 is a B-cell- and macrophage-specific transcription factor. By an electrophoretic mobility shift assay and dimethyl sulfate methylation interference assays, we show that PU.1 binds to DNA sequences within the immunoglobulin kappa 3' enhancer (kappa E3'). Binding of PU.1 to the kappa E3' enhancer assists the binding of a second tissue-restricted factor, NF-EM5, to an adjacent site. Binding of NF-EM5 to kappa E3' DNA sequences requires protein-protein interaction with PU.1 as well as specific protein-DNA interactions. This is the first known instance of PU.1 interacting with another cellular protein. NF-EM5 does not cofractionate with PU.1, suggesting that it is a distinct protein and is not a posttranslational modification of PU.1. UV-crosslinking studies and elution from sodium dodecyl sulfate-polyacrylamide gels indicate that NF-EM5 is a protein of approximately 46 kDa. Site-directed mutagenesis studies of the PU.1- and EM5-binding sites indicate that these sites play important roles in kappa E3' enhancer activity. By using a series of PU.1 deletion constructs, we have identified a region in PU.1 that is necessary for interaction with NF-EM5. This segment encompasses a 43-amino-acid region with PEST sequence homology, i.e., one that is rich in proline (P), glutamic acid (E), serine (S), and threonine (T).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
Site-directed mutagenesis by overlap extension using the polymerase chain reaction
Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., & Pease, L. R. (1989) · Gene · doi:10.1016/0378-1119(89)90358-2 · Cited by 7,399 · cited 1×
“was generated by overlap extension by using the polymerase chain reaction (16).”
MethodThe Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding Proteins
Landschulz, W. H., Johnson, P. F., & McKnight, S. L. (1988) · Science · doi:10.1126/science.3289117 · Cited by 3,443
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
Mitchell, P. J., & Tjian, R. (1989) · Science · doi:10.1126/science.2667136 · Cited by 3,114 · cited 2×
“Several major groups which include zinc finger domains, homeodomains, and basic region domains have been identified (9, 20, 29).”
BackgroundMurre, C., McCaw, P. S., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90682-x · Cited by 2,635 · cited 7×
“PU.1 does not contain sequences homologous to known dimerization domains (leucine zipper and HLH), and thus far there have been no reports of PU.1 interacting with other proteins.”
BackgroundInfluentialAmino Acid Sequences Common to Rapidly Degraded Proteins: The PEST Hypothesis
Rogers, S., Wells, R., & Rechsteiner, M. (1986) · Science · doi:10.1126/science.2876518 · Cited by 2,537 · cited 2×
“Regions rich in these amino acids have been denoted PEST regions, and they may be involved in degradation of intracellular proteins (37).”
BackgroundThe protein Id: A negative regulator of helix-loop-helix DNA binding proteins
Benezra, R., Davis, R. L., Lockshon, D., Turner, D. L., & Weintraub, H. (1990) · Cell · doi:10.1016/0092-8674(90)90214-y · Cited by 2,238 · cited 1×
“Thus, mammalian muscle differentiation and the Drosophila sensory organ patterning pathways can be greatly influenced by the presence of certain HLH dimerization partners (3, 8, 10).”
BackgroundHow eukaryotic transcriptional activators work
Ptashne, M. (1988) · Nature · doi:10.1038/335683a0 · Cited by 1,825
Murre, C., McCaw, P. S., Vaessin, H., Caudy, M., Jan, L. Y., Jan, Y. N., Cabrera, C. V., Buskin, J. N., Hauschka, S. D., Lassar, A. B., et al. (1989) · Cell · doi:10.1016/0092-8674(89)90434-0 · Cited by 1,815
Cited by
Items 201–300 of 352
Petit, B., Chaury, M., Clorennec, C. L., Jaccard, A., Gachard, N., Moalic-Judge, S., Labrousse, F., Cogné, M., Bordessoule, D., & Feuillard, J. (2005) · PubMed · Cited by 46
Cox, P. M., & Goding, C. R. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.151 · Cited by 48
Cytomegalovirus IE2 Protein Stimulates Interleukin 1β Gene Transcription via Tethering to Spi-1/PU.1
Wara-aswapati, N., Yang, Z., Waterman, W. R., Koyama, Y., Tetradis, S., Choy, B. K., Webb, A. C., & Auron, P. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6803 · Cited by 41
Ishimaru, F., & Shipp, M. (1995) · Blood · doi:10.1182/blood.v85.11.3199.bloodjournal85113199 · Cited by 42
Heinz, S., & Glass, C. K. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_142 · Cited by 46
Repression of I-Aβ Gene Expression by the Transcription Factor PU.1
Borràs, F. E., LLoberas, J., Maki, R. A., & Celada, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24385 · Cited by 41
Self-citationTranscriptional regulation of hemopoiesis
Barreda, D. R., & Belosevic, M. (2001) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(01)00035-0 · Cited by 45
Serdobova, I., Pla, M., Reichenbach, P., Sperisen, P., Ghysdael, J., Wilson, A., Freeman, J., & Nabholz, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.7.1211 · Cited by 43
The PU.1/Spi-1 proto-oncogene is a transcriptional regulator of a lentivirus promoter
Carvalho, M., & Derse, D. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.3885-3890.1993 · Cited by 41
Protein Acetylation Regulates Both PU.1 Transactivation and Igκ 3′ Enhancer Activity
Bai, Y., Srinivasan, L., Perkins, L., & Atchison, M. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5160 · Cited by 39
Self-citationCooperative interaction between the DNA-binding domains of PU.1 and IRF4
Yee, A. A., Yin, P., Siderovski, D. P., Mak, T. W., Litchfield, D. W., & Arrowsmith, C. H. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1838 · Cited by 38
IRF4 as an Oncogenic Master Transcription Factor
Wong, R. W. J., Ong, J. Z. L., Theardy, M. S., & Sanda, T. (2022) · Cancers · doi:10.3390/cancers14174314 · Cited by 43
“In fact, IRF4 was first identified as a binding partner of this protein at the immunoglobulin κ3′ enhancer in B cells [12].”
BackgroundInfluentialPongubala, J. M. R., & Atchison, M. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.10304 · Cited by 31
Self-citationKoizumi, H., Horta, M. F., Youn, B., Fu, K. C., Kwon, B. S., Young, J. D., & Liu, C. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.11.6690-6701.1993 · Cited by 44
The dynamic functions of IRF4 in B cell malignancies
Maffei, R., Fiorcari, S., Atene, C. G., Martinelli, S., Mesini, N., Pilato, F., Lagreca, I., Barozzi, P., Riva, G., Nasillo, V., et al. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00968-0 · Cited by 41
NF-κB activity marks cells engaged in receptor editing
Cadera, E. J., Wan, F., Amin, R. H., Nolla, H. A., Lenardo, M. J., & Schlissel, M. S. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20082815 · Cited by 37
“We also observed a several-fold increase in IRF-4 mRNA levels, which is consistent with prior studies showing that IRF-4 plays a role in Ig and Ig locus activation enhancers (Pongubala et al., 1992; Eisenbeis et al., 1995) and is involved in receptor editing (Pathak et al., 2008).”
BackgroundResultLodie, T. A., Reiner, M., Coniglio, S., Viglianti, G., & Fenton, M. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.268 · Cited by 42
Quivy, V., de Walque, S., & Lint, C. M. V. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5466-1_17 · Cited by 41
Hilfinger, J. M., Clark, N. M., Smith, M. J., Robinson, K., & Markovitz, D. M. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.4448-4453.1993 · Cited by 38
Tsukada, J., Misago, M., Serino, Y., Ogawa, R., Murakami, S., Nakanishi, M., Tonai, S., Kominato, Y., Morimoto, I., Auron, P. E., et al. (1997) · Blood · doi:10.1182/blood.v90.8.3142 · Cited by 37
John, S., Marais, R., Child, R., Light, Y., & Leonard, W. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.743 · Cited by 35
Transcription of the blk Gene in Human B Lymphocytes Is Controlled by Two Promoters
Lin, Y.-H., Shin, E. J., Campbell, M. J., & Niederhuber, J. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25968 · Cited by 34
Goffin, V., Demonté, D., Vanhulle, C., de Walque, S., de Launoit, Y., Burny, A., Collette, Y., & Lint, C. V. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki720 · Cited by 37
“An SmaI–XhoI fragment containing the HIV-1 LAI 50-LTR (nt 1–789) was purified from the previously described pLTR(1-789)-luc construct (9).”
MethodDekoninck, A., Calomme, C., Nizet, S., de Launoit, Y., Burny, A., Ghysdael, J., & Lint, C. M. V. (2003) · Oncogene · doi:10.1038/sj.onc.1206392 · Cited by 38
“In fact, many target genes for PU.1 have been identified in B cells (k 30 enhancer, Pongubala et al., 1992, 1993, l2–4 enhancer, Eisenbeis et al., 1993, heavy chain Em enhancer, Nelsen et al., 1993, J chain promoter, Shin and Koshland 1993, and Btk promoter, Himmelmann et al., 1996), myeloid cells…”
BackgroundHume, D. A. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0312166 · Cited by 40
Dynamic Control of Long-Range Genomic Interactions at the Immunoglobulin κ Light-Chain Locus
de Almeida, C. R., Hendriks, R. W., & Stadhouders, R. (2015) · Advances in immunology · doi:10.1016/bs.ai.2015.07.004 · Cited by 36
“However, after lymphoid progenitors have committed to the B cell fate, the importance of PU.1 seems to diminish—suggesting that PU.1 does not play a leading role in rearrangement of the Igκ locus.”
BackgroundMethodInfluentialStructural Studies of IRF4 Reveal a Flexible Autoinhibitory Region and a Compact Linker Domain
Remesh, S. G., Santosh, V., & Escalante, C. R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.678789 · Cited by 36
Marshall, L. J., Moore, L. D., Mirsky, M. M., & Major, E. O. (2011) · Journal of General Virology · doi:10.1099/vir.0.035832-0 · Cited by 32
Identification of three genes up-regulated in PU.1 rescued monocytic precursor cells
Henkel, G. W. (2002) · International Immunology · doi:10.1093/intimm/dxf040 · Cited by 31
“The N-PU.1 (1297) polyclonal antiserum was previously reported ( 33 ).”
BackgroundSpi-C Has Opposing Effects to PU.1 on Gene Expression in Progenitor B Cells
Schweitzer, B. L., Huang, K. J., Kamath, M. B., Emelyanov, A. V., Birshtein, B. K., & DeKoter, R. P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2195 · Cited by 33
Constitutively expressed Oct-2 prevents immunoglobulin gene silencing in myeloma × T cell hybrids
Radomska, H. S., Shen, C.-P., Kadesch, T. R., & Eckhardt, L. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90034-5 · Cited by 32
Context dependent transactivation domains activate the immunoglobulin mu heavy chain gene enhancer.
Erman, B., & Sen, R. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00843.x · Cited by 33
PU.1 Can Recruit BCL6 to DNA To Repress Gene Expression in Germinal Center B Cells
Wei, F., Zápražná, K., Wang, J., & Atchison, M. L. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00234-09 · Cited by 34
Self-citationBlasquez, V. C., Hale, M. A., Trevorrow, K. W., & Garrard, W. T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35920-9 · Cited by 30
Pi, a pre-B-cell-specific enhancer element in the immunoglobulin heavy-chain enhancer.
Libermann, T. A., & Baltimore, D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.5957 · Cited by 29
PU.1 Binds to a Distal Regulatory Element That Is Necessary for B Cell-Specific Expression of CIITA
Yoon, H., & Boss, J. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000079 · Cited by 29
Uranishi, M., Iida, S., Sanda, T., Ishida, T., Tajima, E., Ito, M., Komatsu, H., Inagaki, H., & Ueda, R. (2005) · Leukemia · doi:10.1038/sj.leu.2403833 · Cited by 34
Das, S., Nikolaidis, N., & Nei, M. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.05.180 · Cited by 28
“These enhancers contain specific nucleotide motifs that bind to specific transcription factors (Lenardo et al., 1987; Pongubala et al., 1992; Schanke and Van Ness, 1994).”
The transcription factor PU.1 does not regulate lineage commitment but has lineage-specific effects
McKercher, S. R., Henkel, G. W., & Maki, R. A. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.5.727 · Cited by 28
“NF-EM5 [ 6 , 7], which was subsequently cloned, identified as a member of the interferon regulatory factor (IRF) family, and called PIP [8], was shown to associate with PU.1 after phosphorylation at Ser148.”
BackgroundSelf-citationAn activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia
Cherian, M. A., Olson, S. L., Sundaramoorthi, H., Cates, K. L., Cheng, X., Harding, J., Martens, A., Challen, G. A., Tyagi, M. G., Ratner, L., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000164 · Cited by 29
Regulation of Human B19 Parvovirus Promoter Expression by hGABP (E4TF1) Transcription Factor
Vassias, I., Hazan, U., Michel, Y. M., Sawa, C., Handa, H., Gouya, L., & Morinet, F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8287 · Cited by 27
Hashimoto, S.-I., Nishizumi, H., Hayashi, R., Tsuboi, A., Nagawa, F., Takemori, T., & Sakano, H. (1999) · International Immunology · doi:10.1093/intimm/11.9.1423 · Cited by 27
PU.1/Spi-1 Is Essential for the B Cell-Specific Activity of the Mouse CD72 Promoter
Ying, H., Chang, J.-F., & Parnes, J. R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.5.2287 · Cited by 28
Transcriptional Control of Pre-B Cell Development and Leukemia Prevention
Pang, S. H. M., Carotta, S., & Nutt, S. L. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_377 · Cited by 31
“1 and Spi-B have been shown to recruit IRF4 or IRF8 to ETS-IRF composite elements (EICE) located in the Ej3’ and Igk enhancers (Brass et al. 1999; Eisenbeis et al. 1995; Escalante et al. 2002; Pongubala et al. 1992).”
BackgroundThe Igκ3′ Enhancer Is Activated by Gradients of Chromatin Accessibility and Protein Association
McDevit, D. C., Perkins, L., Atchison, M. L., & Nikolajczyk, B. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2834 · Cited by 27
“Preliminary data showing no change in PU.1/ 3 association in EMSA following in vitro PU.1 phosphorylation by CK2 may or may not be relevant to effects on the endogenous chromatinized locus.”
BackgroundSelf-citationBolwig, G. M., Bruder, J. T., & Hearing, P. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.24.6555 · Cited by 29
The λ5–VpreB1 locus—a model system for studying gene regulation during early B cell development
Sabbattini, P. M. R., & Dillon, N. (2005) · Seminars in Immunology · doi:10.1016/j.smim.2005.01.004 · Cited by 29
Jiménez-Ramírez, C., Brooks, A. J., Forshell, L. P., Yakimchuk, K., Zhao, B., Fulgham, T. Z., & Sample, C. E. (2006) · Journal of Virology · doi:10.1128/jvi.00897-06 · Cited by 29
“1 recruits IRF-4 to activate transcription (13, 63).”
BackgroundPU.1 as a chromatin accessibility factor for immunoglobulin genes
Marecki, S., McCarthy, K. M., & Nikolajczyk, B. S. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2003.08.007 · Cited by 25
Carvalho, M. D. G., Kirkland, M. A., & Derse, D. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6586-6595.1993 · Cited by 27
Pedchenko, T. V., Park, G. Y., Joo, M., Blackwell, T. S., & Christman, J. W. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00046.2005 · Cited by 24
Soodgupta, D., White, L. S., Yang, W., Johnston, R., Andrews, J. M., Kohyama, M., MURPHY, K. M. M., Mosammaparast, N., Payton, J. E., & Bednarski, J. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.026 · Cited by 27
“1 forms heterodimeric complexes with IRF4 or IRF8 to promote transcription (Brass et al., 1996; Heinz et al., 2010; Pongubala et al., 1992).”
BackgroundDifferential Cooperation between Regulatory Sequences Required for Human CD53 Gene Expression
Hernández-Torres, J., Yunta, M., & Lazo, P. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104723200 · Cited by 27
Regulation of gene expression at early stages of B-cell and T-cell differentation
Fitzsimmons, D., & Hagman, J. R. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80054-9 · Cited by 28
Mouse μ Opioid Receptor Gene Expression
Choe, C.-Y., Im, H., KO, J. L., & Loh, H. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.34926 · Cited by 24
Plasma Cell Formation, Secretion, and Persistence: The Short and the Long of It
Bayles, I., & Milcarek, C. (2014) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2014012168 · Cited by 23
Mutants of ETS domain PU.1 and GGAA/T recognition: Free energies and kinetics
Pio, F., Assa‐Munt, N., Yguerabide, J., & Maki, R. A. (1999) · Protein Science · doi:10.1110/ps.8.10.2098 · Cited by 22
“Some ternary complexes composed of PU.1 or ETS-1 with other transcription factors binding to adjacent sites have been characterized ~Pongubala et al., 1992, 1993; Brass et al., 1996; Erman & Sen, 1996; Nikolajczyk et al., 1996!. Recently, the first crystal structure of the ETS domain of PU.1…”
BackgroundSelf-citationPhospholipase Cγ2 Contributes to Light-Chain Gene Activation and Receptor Editing
Bai, L., Chen, Y., He, Y., Dai, X., Lin, X., Wen, R., & Wang, D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02273-06 · Cited by 22
Srikanth, S., & Rado, T. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31680-6 · Cited by 24
Critical Functions of IRF4 in B and T Lymphocytes
Hagman, J. R. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701385 · Cited by 24
“in ternary complexes including the Igk L chain gene 39 enhancer (2).”
BackgroundHensold, J. O., Stratton, C. A., Barth, D., & Galson, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3385 · Cited by 21
ELF-1 Interacts with and Transactivates the IgH Enhancer π Site
Akbarali, Y., Oettgen, P., Boltax, J., & Libermann, T. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26007 · Cited by 23
Characterization of the human and mouse Fli-1 promoter regions
Barbeau, B., Bergeron, D., Beaulieu, J., Nadjem, Z., & Rassart, É. (1996) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(96)00060-7 · Cited by 24
Mao, F., Lin, Y. N., Zhou, Y., He, Z., Li, J., Zhang, Y., & Yu, Z. (2018) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2018.07.027 · Cited by 22
Wittekindt, N. E., Hörtnagel, K., Geltinger, C., & Polack, A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.3.800 · Cited by 23
The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1
Barbeau, B., Barat, C., Bergeron, D., & Rassart, É. (1999) · Oncogene · doi:10.1038/sj.onc.1202913 · Cited by 24
“These could thus be Spi-1-related degraded products which have been previously reported in analysis of EBS elements with myeloid-derived cell lines (Pongubala et al., 1992; Carvalho and Derse, 1993a; Feinman et al., 1994; Eichbaum et al., 1994).”
Nagulapalli, S., Goheer, A., Pitt, L. K., McIntosh, L. P., & Atchison, M. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7337-7350.2002 · Cited by 22
Self-citationContext-dependent Pax-5 repression of a PU.1/NF-κB regulated reporter gene in B lineage cells
Linderson, Y., French, N. S., Neurath, M. F., & Pettersson, S. (2001) · Gene · doi:10.1016/s0378-1119(00)00546-1 · Cited by 19
Liu, X., Prabhu, A., & Ness, B. V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3285 · Cited by 19
Carlsson, R., Persson, C., & Leanderson, T. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(03)00032-4 · Cited by 21
The Ets family of transcription factors
Wasylyk, B., Hahn, S. L., & Giovane, A. (1994) · Springer eBooks · doi:10.1007/978-3-642-78757-7_2 · Cited by 260
Backbone dynamics of a short PU.1 ETS domain 1 1Edited by P. E. Wright
Jia, X., Lee, L. K., Light, J. P., Palmer, A. G. I., & Assa‐Munt, N. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3123 · Cited by 22
Gross, S. A., Zheng, J. H., Le, A. T., Kerzic, P. J., & Irons, R. (2006) · Cell Biology and Toxicology · doi:10.1007/s10565-006-0128-7 · Cited by 19
“Because PU.1 is also expressed in B cells (Pongubala et al., 1992), we used the pan-B-cell antigen CD19 to deplete the MNC fraction of pre-B cells prior to the isolation of CD34+ HPC. CD19+ cells were removed using a fluorescein isothiocynate (FITC) conjugated anti-CD19 monoclonal antibody (Ab)…”
Crystallization and characterization of PU.1/IRF-4/DNA ternary complex
Escalante, C. R., Shen, L., Escalante, M. C., Brass, A. L., Edwards, T. A., Singh, H., & Aggarwal, A. K. (2002) · Journal of Structural Biology · doi:10.1016/s1047-8477(02)00514-2 · Cited by 20
Genetic analysis of transcription factors implicated in B lymphocyte development
Singh, H. (1994) · Immunologic Research · doi:10.1007/bf02935619 · Cited by 18
“PU.I recruits a distinct transcription factor, NF-EM5, to the Ig kappa 3' and lambda 2-4 enhancers [ 58 , 59].”
BackgroundTransfer of antigen between dendritic cells in the stimulation of primary T cell proliferation
Knight, S. C., Iqball, S., Roberts, M. S., Macatonia, S., & Bedford, P. A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199805)28:05<1636::aid-immu1636>3.0.co;2-9 · Cited by 90
Role of the Transcription Factor BSAP (Pax-5) in B-Cell Development
Busslinger, M., & Nutt, S. L. (1998) · Humana Press eBooks · doi:10.1007/978-1-4757-2778-4_6 · Cited by 17
Meyer, K. B., & Ireland, J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.9.1576 · Cited by 17
Liu, H., Duan, Z., Zheng, H., Hu, D., Li, M., Tao, Y., Bode, A. M., Dong, Z., & Cao, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032624 · Cited by 16
Chang, L., & Thompson, M. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6467 · Cited by 22
Hensold, J., Stratton, C. A., & Barth, D. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.14.2869 · Cited by 16
Multiple Regulatory Elements Control the Basal Promoter Activity of the Human α4 Integrin Gene
AUDET, J.-F., Masson, J., Rosen, G., Salesse, C., & Guérin, S. L. (1994) · DNA and Cell Biology · doi:10.1089/dna.1994.13.1071 · Cited by 18
“Recently, PU.l, a member of the Ets family of transcription factors, was shown to recruit, through proteinprotein interactions, the binding of a second B-cell-re-stricted nuclear factor, designated NF-EM5, in the 3' enhancer of the immunoglobulin k gene (Pongubala et al., 1992, 1993).”
Heydemann, A., Boehmler, J. H., & Simon, M. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29527 · Cited by 16
Confirming the Functional Importance of a Protein–DNA Interaction
Carey, M., Peterson, C. L., & Smale, S. T. (2012) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top070060 · Cited by 17
“5, lane 1) (Pongubala et al. 1992).”
The hematopoietic cell-specific transcription factor PU.1 is critical for expression of CD11c
Yashiro, T., Kasakura, K., Oda, Y., Kitamura, N., Inoue, A., Nakamura, S., Yokoyama, H., Fukuyama, K., Hara, M., Ogawa, H., et al. (2017) · International Immunology · doi:10.1093/intimm/dxx009 · Cited by 14
McKercher, S. R., Lombardo, C. R., Bobkov, A. A., Jia, X., & Assa‐Munt, N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0136910100 · Cited by 15
Self-citationPKCη directs induction of IRF-4 expression and Ig κ gene rearrangement in pre-BCR signaling pathway
Oda, A., Ono, T., Yamamoto, M., Goitsuka, R., & Kitamura, D. (2008) · International Immunology · doi:10.1093/intimm/dxn101 · Cited by 13
Yamada, T., Suzuki, M., Satoh, H., Kihara‐Negishi, F., Nakano, H., & Oikawa, T. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.10.023 · Cited by 14
The murine AIDS defective provirus acts as an insertional mutagen in its infected target B cells
Huang, M., Takáč, M., Kozak, C. A., & Jolicoeur, P. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4069-4078.1995 · Cited by 16
Dual function of the intron of the rat insulin I gene in regulation of gene expression
Damert, A., Leibiger, B., & Leibiger, I. B. (1996) · Diabetologia · doi:10.1007/bf02658502 · Cited by 13
“1 [31] and G A B P [32] and an oligonucleotide covering nucleotides +87 to + 110 show the formation of very similar retarded complexes with HIT nuclear extracts (I.”
BackgroundShen, H. M., Peters, A., Kao, D. J., & Storb, U. (2001) · International Immunology · doi:10.1093/intimm/13.5.665 · Cited by 12
Somatic Hypermutation of Immunoglobulin Genes
Storb, U. (1998) · Springer eBooks · doi:10.1007/978-3-662-13141-1_4 · Cited by 12
Plaza, S., Grévin, D., MacLeod, K., Stéhelin, D., & Saule, S. (1994) · Europe PMC (PubMed Central) · Cited by 14
Regulation of immunoglobulin gene transcription
Calame, K. L., & Ghosh, S. (1995) · Elsevier eBooks · doi:10.1016/b978-012053640-5/50021-5 · Cited by 13
Torlakovic, E., Małecka, A., Myklebust, J. H., Tierens, A. M., Aasheim, H., Nesland, J. M., Smeland, E. B., Kvaløy, S., & Delabie, J. (2005) · The Journal of Pathology · doi:10.1002/path.1777 · Cited by 15
A.M.El-Gazzar, M., Maeda, K., Nomiyama, H., Nakao, M., Kuwahara, K., & Sakaguchi, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106696200 · Cited by 11
Transcription of Immunoglobulin Genes
Calame, K. L., & Sen, R. (2004) · Elsevier eBooks · doi:10.1016/b978-012053641-2/50007-1 · Cited by 13
Larouche, K., Leclerc, S., Giasson, M., & Guérin, S. L. (1996) · DNA and Cell Biology · doi:10.1089/dna.1996.15.779 · Cited by 11
“Finally, the molecular mass obtained for Bp5 is close to that of two Ets family members: PU1 (Pongubala et al, 1992) and Ergl (Rao et al, 1987; Reddy et al, 1987).”
Glozak, M. A., & Blomberg, B. B. (1996) · Molecular Immunology · doi:10.1016/0161-5890(95)00146-8 · Cited by 10
Hodawadekar, S., Park, K., Farrar, M. A., & Atchison, M. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102239 · Cited by 12
“1 DNA binding at the kE39 enhancer functions to nucleate binding of other enhancer factors (16, 31, 39).”
BackgroundSelf-citation
Metadata
- Authors
- Pongubala, J. M., Nagulapalli, S., Klemsz, M. J., McKercher, S. R., Maki, R. A., & Atchison, M. L.
- Affiliations
- University of Pennsylvania (US)
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1992-01
- Volume
- 12
- Issue
- 1
- Pages
- 368-378
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC364131
- OpenAlex
- W1909754239
- Cited by
- 354
- References
- 48
- Citations by year
- 2025: 2 · 2023: 1 · 2022: 6 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 6 · 2016: 5 · 2015: 4 · 2014: 6 · 2013: 1 · 2012: 7
- FWCI
- 11.00
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ai030656-08)
- National Institute of General Medical Sciences (R01GM042415)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- PU.1, enhancer activity, transcription factor binding sites, protein-protein interaction, PEST sequence, DNA binding specificity
- MeSH terms
- Base Sequence, Binding Sites, Cell Line, DNA, DNA-Binding Proteins, Electrophoresis, Polyacrylamide Gel, Enhancer Elements, Genetic, Immunoglobulin kappa-Chains, Molecular Sequence Data, Nuclear Proteins, Organ Specificity, Transcription Factors, Retroviridae Proteins, Oncogenic, Mutagenesis, Site-Directed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.